Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward

The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xue-Lian, Hu, Shang-Ying, Hu, Jia-Wei, Wang, Hong-Hao, Wen, Tian-Meng, Feng, Yu-Shu, Qiao, You-Lin, Zhao, Fang-Hui, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512493/
https://www.ncbi.nlm.nih.gov/pubmed/37735709
http://dx.doi.org/10.1186/s40249-023-01136-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512493/
https://www.ncbi.nlm.nih.gov/pubmed/37735709
http://dx.doi.org/10.1186/s40249-023-01136-6

Ejemplares similares